The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC)

Results from a prospective observational reference laboratory testing programView graphical summary page of abstract  

Molecular Tumor Board: 39 year old female with history of advanced stage squamous cell cervical cancer, new lung mass and PIK3CA mutation

For patients who present with advanced stage cervical cancer, targeted therapies can improve outcomes. Join us for a molecular tumor board as we discuss treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care.